ICCM Valuation

Icecure Medical Ltd

Add to Watchlist

Advanced Chart

1.040

0(0.000%)1D

Overview
Forecast
Valuation
Earnings

ICCM Relative Valuation

ICCM's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ICCM is overvalued; if below, it's undervalued.

Historical Valuation

Icecure Medical Ltd (ICCM) is now in the Overvalued zone, suggesting that its current forward PS ratio of 18.49 is considered Overvalued compared with the five-year average of -5.25. The fair price of Icecure Medical Ltd (ICCM) is between 0.45 to 0.81 according to relative valuation methord. Compared to the current price of 1.07 USD , Icecure Medical Ltd is Overvalued By 32.08%.

Relative Value

Fair Zone

0.45-0.81

Current Price：1.07

32.08%

Overvalued

-4.29

Trailing

Forward

0.00

EV/EBITDA

Icecure Medical Ltd. (ICCM) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.

-5.41

EV/EBIT

Icecure Medical Ltd. (ICCM) has a current EV/EBIT of -5.41. The 5-year average EV/EBIT is -4.53. The thresholds are as follows: Strongly Undervalued below -19.60, Undervalued between -19.60 and -12.07, Fairly Valued between 3.00 and -12.07, Overvalued between 3.00 and 10.53, and Strongly Overvalued above 10.53. The current Forward EV/EBIT of -5.41 falls within the Historic Trend Line -Fairly Valued range.

18.49

Icecure Medical Ltd. (ICCM) has a current PS of 18.49. The 5-year average PS is 14.93. The thresholds are as follows: Strongly Undervalued below -16.52, Undervalued between -16.52 and -0.80, Fairly Valued between 30.65 and -0.80, Overvalued between 30.65 and 46.37, and Strongly Overvalued above 46.37. The current Forward PS of 18.49 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/OCF

Icecure Medical Ltd. (ICCM) has a current P/OCF of 0.00. The 5-year average P/OCF is -1.43. The thresholds are as follows: Strongly Undervalued below -5.89, Undervalued between -5.89 and -3.66, Fairly Valued between 0.80 and -3.66, Overvalued between 0.80 and 3.03, and Strongly Overvalued above 3.03. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

-8.87

P/FCF

Icecure Medical Ltd. (ICCM) has a current P/FCF of -8.87. The 5-year average P/FCF is -2.70. The thresholds are as follows: Strongly Undervalued below -7.34, Undervalued between -7.34 and -5.02, Fairly Valued between -0.39 and -5.02, Overvalued between -0.39 and 1.93, and Strongly Overvalued above 1.93. The current Forward P/FCF of -8.87 falls within the Strongly Undervalued range.

Icecure Medical Ltd (ICCM) has a current Price-to-Book (P/B) ratio of 10.06. Compared to its 3-year average P/B ratio of 4.28 , the current P/B ratio is approximately 134.87% higher. Relative to its 5-year average P/B ratio of 4.93, the current P/B ratio is about 104.13% higher. Icecure Medical Ltd (ICCM) has a Forward Free Cash Flow (FCF) yield of approximately -18.77%. Compared to its 3-year average FCF yield of -28.41%, the current FCF yield is approximately -33.92% lower. Relative to its 5-year average FCF yield of -25.75% , the current FCF yield is about -27.09% lower.

10.06

P/B

Median3y

4.28

Median5y

4.93

-18.77

FCF Yield

Median3y

-28.41

Median5y

-25.75

Competitors Valuation Multiple

The average P/S ratio for ICCM's competitors is 7.25, providing a benchmark for relative valuation. Icecure Medical Ltd Corp (ICCM) exhibits a P/S ratio of 18.49, which is 154.88% above the industry average. Given its robust revenue growth of -2.42%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

Baird Medical Investment Holdings Ltd

Wrap Technologies Inc

Performance Decomposition

Market capitalization of ICCM increased by 47.73% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -2.43 to -3.61.

The secondary factor is the Margin Expansion, contributed 1.89%to the performance.

Overall, the performance of ICCM in the past 1 year is driven by P/E Change. Which is more unsustainable.

-2.42%

743.00K → 725.00K

Revenue Growth

1.89%

-485.73 → -494.90

Margin Expansion

48.26%

-2.43 → -3.61

P/E Change

47.73%